An Arm and a Leg

Dan Weissmann

Booking Overview

A witty, issue-driven show about why healthcare costs so much—and what policies, systems, and incentives might actually help lower them. It’s especially useful for PR pros representing healthcare, legal, and consumer-advocacy experts who can explain how pricing power, insurance rules, and regulation affect real people.

Metrics

Episodes: 165

Frequency: Irregular

Rating: 4.8/5.0

Estimated listeners: 10k-100k

Gender skew: Neutral

Location: USA

Instagram: 1.0k followers

30s Ad: 593 - 730, 60s Ad: 707 - 844

Contact Information

Contact Form

Contact form available - Official Form

Host

Dan Weissmann - Created, hosted, and produced An Arm and a Leg. A seasoned journalist focused on healthcare costs and the policies/system incentives behind medical pricing and access, co-produced with KFF Health N...

Booking Intelligence

Booking Requirements

medium
Typical Credentials:  
Clinicians, health policy researchers, legal experts (healthcare, drug/patent law, antitrust/regulation), consumer advocates, and industry/policy insiders who can explain complex healthcare cost drivers in plain language.
Required Achievements:  
Published work on health costs/access (reports, academic papers, major media features), Role in policy reform or advocacy organizations, Authored books or widely cited expertise in healthcare pricing/insurance/mental health access, Legal expertise demonstrated through high-profile cases or advisory work

Recent Guest Discussions

Linda Michaels - Tech Intermediaries In Therapy Workflows, Privacy/confidentiality Risks From Recording/transcription, And Policy Efforts To Encourage More Therapists To Stay In-network

Al Engelberg - History And Incentives Of The Drug Patent System, Generic Drug Market Dynamics, And Proposed Fixes To High Drug Prices

Recent Topics

Healthcare, Health Policy, Drug Pricing, Insurance, Mental Health, Patents, Consumer Advocacy, Antitrust, Bioethics

Episodes

Here's the recent few episodes on
An Arm and a Leg
:

The Chatbot Will See You Now: Big Tech In Therapy (from Organized Money)

May 21, 2026

One place you might assume is safe from prying ears is your therapy session.  But as more therapists struggle to negotiate with insurers, they’re turning to tech middlemen like BetterHelp and Headway that promise to take care of the insurance admin and match them with patients.  And these companies are sometimes recording and transcribing your sessions — and then turning around and sharing that data with social media companies and investors. And there are concerns that t...

The Supreme Court case that could slow generic drugs

April 27, 2026

It’s a case you’ve (probably) never heard of: This week, the Supreme Court is hearing oral arguments in Hikma v. Amarin — a legal battle that could impact how much you ultimately pay for prescription drugs.  Here’s why the case matters: As soon as a generic version of a brand-name drug comes to market, its price typically drops by half. Within 10 years, by more than 75%. Meaning: the sooner we have access to generics, the less we pay at the pharmacy counter. ...

Why drugs cost so much, 101: Medicine monopolies

April 09, 2026

We’re always asking: Why do drugs cost so freaking much?  And it’s a complicated question. There are a bunch of reasons — to be sure. But in our reporting over the years, like our stories on insulin and tuberculosis drugs, experts cited one big reason over and over again:  The pharmaceutical industry wages sophisticated legal battles to keep monopoly control over their best selling, most lucrative drugs — blocking generic competition, and increasing thei...

Get your clients booked on top podcasts

Try us risk free with a FREE 3 days trial.

Start Your Free Trial

Join hundreds of PR teams using Podseeker to pitch and land bookings